河南金丹乳酸科技股份有限公司 二、关于 2023 年半年度募集资金存放与使用情况的独立意见 经核查，我们认为：公司 2023 年半年度募集资金的存放和使用符合中国证 监会、深圳证券交易所关于上市公司募集资金存放和使用的相关规定，不存在 募集资金存放和使用违规的情况，不存在改变或变相改变募集资金投向和损害 股东利益的情况。公司编制的《2023 年半年度募集资金存放与使用情况的专项 报告》内容真实、准确、完整，不存在虚假记载、误导性陈述或重大遗漏。 独立董事关于第五届董事会第五次会议相关事项的独立意见 根据《上市公司独立董事规则》《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 等法律法规以及《公司章程》的有关规定，作为河南金丹乳酸科技股份有限公 司（以下简称"公司"）第五届董事会的独立董事，我们本着认真严谨、实事求 是的态度，对公司第五届董事会第五次会议有关事项发表如下独立意见： 一、关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项 说明和独立意见 根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管 要求》的规定，我们 ...

| 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2023-051 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 第五届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 河南金丹乳酸科技股份有限公司（以下简称"公司"）第五届董事会第五 次会议于 2023 年 8 月 28 日上午 9:00 以现场结合通讯方式在公司会议室召开， 会议通知于 2023 年 8 月 18 日以电话及电子邮件方式发出。 本次会议由公司董事长张鹏先生主持。本次会议应出席董事 7 名，实际出 席董事 7 名，其中余龙、张复生、赵永德以通讯表决方式出席会议。公司全体 监事、高级管理人员列席了会议。本次会议的召集和召开符合国家有关法律、 法规及《公司章程》的规定，决议合法有效。 二、董事会会议审议情况 经与会董事充分讨论，本次会议审议并通过了如下议案： （一）审议通过《关于公司<2023 年半年度报告>及其摘要的议案》。 经审议，董事会认为： ...

| 证券代码：300829 | 证券简称：金丹科技 | 公告编号：2023-055 | | --- | --- | --- | | 债券代码：123204 | 债券简称：金丹转债 | | 河南金丹乳酸科技股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 根据《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要 求》等有关规定，河南金丹乳酸科技股份有限公司（以下简称"公司"、"本公司" 或"金丹科技"）将 2023 年半年度募集资金存放与使用情况专项报告如下： 一、募集资金基本情况 经中国证券监督管理委员会证监许可[2020]413 号文核准，并经深圳证券交 易所同意，本公司由主承销商国金证券股份有限公司于 2020 年 4 月 13 日向社会 公众公开发行普通股（A 股）股票 2,830 万股，每股面值 1 元，每股发行价人民 币 22.53 元，共募集资金 637,599,000.00 元，扣除发行费用 9 ...

Group 1: Financial Performance - The company's revenue and net profit decreased in Q1 2023 due to lower sales volume and prices of lactic acid products, alongside rising costs of raw materials like corn and coal compared to the same period last year [2][3] - The gross profit margins for 2020, 2021, and 2022 were 27.42%, 19.04%, and 20.87% respectively [5] - The basic earnings per share for 2022 was 0.73 yuan, with a return on equity of 9.03% [15] Group 2: Industry Position and Strategy - The company aims to extend its business along the industrial chain through technology introduction and cooperation, enhancing integration and reducing operational costs [3] - The global lactic acid production capacity increased from 750,000 tons in 2021 to 995,000 tons in 2022, a growth of 32.67% [7] - The company is positioned as a leading producer in the lactic acid industry, with a production capacity of 183,000 tons of lactic acid and its derivatives [11] Group 3: Product Development and Market Expansion - The company plans to use raised funds primarily for the construction of a 75,000-ton annual capacity polylactic acid (PLA) biodegradable materials project, aiming to meet the growing domestic and international demand [3][4] - The company has developed a full industrial chain from corn planting to lactic acid production, and further to downstream products like glycolic acid and PLA [7][11] - The company is actively exploring new markets in sectors such as leisure food, cosmetics, and pre-prepared meals [7] Group 4: Competitive Advantages - The company has over 40 patents related to lactic acid and its derivatives, enhancing its technological edge [11][14] - The company benefits from a rich supply of corn, located in a major corn-producing area, which helps stabilize raw material costs [12] - The company has established a strong sales network across 20 provinces in China and exports to over 90 countries, building a solid customer base [13] Group 5: Future Outlook and Challenges - The company is focused on addressing market competition by enhancing market analysis, adopting advanced technologies, and improving management efficiency [6][9] - The implementation of plastic restrictions is expected to increase the demand for biodegradable plastics, presenting growth opportunities for the company [9][10] - The company is committed to maintaining steady growth in performance and enhancing investor confidence through effective management and governance [15]

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2023-001 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------------|---------------------------------------|------------------------------------------------------| | 投资者关系活动 | □特定对象调研 □ | 分析师会议 | | 类别 | □ 媒体采访 √ | 业绩说明会 | | | □ 新闻发布会 □ | 路演活动 | | | □ 现场参观 | | | | √ 其他：河南辖区上市公司 | 2023 年投资者网上集体接待日活动 | | 参与单位名称及 | | | | | 全体投资者 | | | 人员姓名 | | | | 时间 | 2023 年 5 月 18 | 日（星期四）下午 14:30~17:30 | | 地点 | 全景网"投资者关系互动平台"（ | https://ir.p5w.net） | | 上市公司接待人 | 1、董事长张鹏 ...

证券代码：300829 证券简称：金丹科技 公告编号：2023-033 河南金丹乳酸科技股份有限公司 关于参加河南辖区上市公司 2023 年投资者网上集体接待日 活动暨召开 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 河南金丹乳酸科技股份有限公司（以下简称"公司"）于 2023 年 4 月 21 日 发布了公司《2022 年年度报告》，为便于广大投资者更全面深入地了解公司 2022 年度经营成果、财务状况，进一步加强与投资者的互动交流，公司定于 2023 年 5 月 18 日（星期四）16:00-17:20 在全景网参加"真诚沟通 传递价值"河南辖 区上市公司 2023 年投资者网上集体接待日活动暨举办 2022 年度业绩说明会，就 投资者关心的问题进行交流。本次活动将采用网络远程的方式举行，投资者可登 录"全景·路演天下"(http:/rs.p5w.net)参与本次互动交流。 出席本次活动的人员有：公司董事长张鹏先生、董事会秘书崔耀军先生、财 务总监陈飞先生、保荐代表人解明先生、独立董事张复生先生（如有特殊情况， 参会人员 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥324,258,192.62, a decrease of 14.12% compared to ¥377,584,484.39 in the same period last year[4] - Net profit attributable to shareholders decreased by 64.01% to ¥15,543,631.08 from ¥43,185,548.57 year-on-year[4] - The net profit after deducting non-recurring gains and losses fell by 66.20% to ¥13,583,173.25 compared to ¥40,191,601.14 in the previous year[4] - The net profit for the first quarter of 2023 is CNY 13,000,277.81, a decrease of 69.5% compared to CNY 42,585,093.25 in the same period last year[18] - The total revenue from operating activities decreased to CNY 324,555,049.55, down 6.4% from CNY 348,317,821.29 in the previous year[20] - The company reported a total comprehensive income of CNY 12,994,664.40, down 69.6% from CNY 42,782,635.56 in the previous year[18] - The company's operating profit for the first quarter is CNY 14,877,662.83, a decrease of 68.3% from CNY 46,911,171.33 in the same period last year[18] Cash Flow and Assets - The net cash flow from operating activities was negative at -¥24,689,688.78, a decline of 219.11% from ¥20,727,718.72 in the same period last year[4] - The net cash flow from operating activities is negative at CNY -24,689,688.78, compared to a positive CNY 20,727,718.72 in the same period last year[21] - Cash and cash equivalents at the end of the period increased to CNY 413,968,610.61, compared to CNY 248,188,732.85 at the end of the same period last year[21] - The company's cash and cash equivalents reached 417,765,443.11 yuan, significantly up from 262,311,763.07 yuan, marking a growth of 59.4%[14] - The company's total assets increased to 2,844,969,736.54 yuan, up from 2,506,336,264.56 yuan at the beginning of the year, representing a growth of 13.5%[15] - Current assets rose to 882,937,445.82 yuan, an increase of 30% from 679,880,037.39 yuan at the start of the year[14] - The total liabilities of the company were reported at 1,289,756,535.43 yuan, compared to 964,117,727.84 yuan previously, reflecting a 33.8% increase[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 18,064[9] - The equity attributable to shareholders increased by 1.02% to ¥1,541,931,717.94 from ¥1,526,392,016.25 at the end of the previous year[4] - The equity attributable to shareholders of the parent company was 1,541,931,717.94 yuan, up from 1,526,392,016.25 yuan, showing a slight increase of 1%[15] Operational Challenges - The decline in net profit was primarily due to decreased sales and prices of lactic acid products and increased prices of key raw materials like corn and coal[8] - The total operating costs amounted to 312,580,589.55 yuan, down 6.3% from 333,632,362.38 yuan year-on-year[16] - The net profit margin for the period was impacted by increased research and development expenses, which totaled 9,980,229.02 yuan, compared to 13,279,160.25 yuan in the previous period, reflecting a decrease of 24.3%[16] Strategic Initiatives - The company has received government subsidies amounting to ¥2,861,681.54 during the reporting period[5] - The company plans to issue convertible bonds to unspecified investors, which has been approved by the Shenzhen Stock Exchange[11] - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[16]

Financial Performance - The company's operating revenue for 2022 was ¥1,534,615,763.09, representing a 6.41% increase compared to ¥1,438,361,302.74 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥132,230,306.43, a 2.36% increase from ¥132,711,426.20 in 2021[21]. - The net profit after deducting non-recurring gains and losses was ¥128,909,384.66, showing a significant increase of 21.00% from ¥110,063,045.66 in 2021[21]. - The net cash flow from operating activities reached ¥161,589,312.52, a remarkable increase of 209.94% compared to ¥48,729,701.04 in 2021[21]. - The total assets at the end of 2022 amounted to ¥2,506,336,264.56, reflecting a 14.95% increase from ¥2,185,402,728.73 at the end of 2021[21]. - The net assets attributable to shareholders increased by 8.45% to ¥1,526,392,016.25 at the end of 2022, up from ¥1,411,047,163.27 in 2021[21]. - The basic earnings per share for 2022 was ¥0.73, a slight increase of 1.39% from ¥0.72 in 2021[21]. - The company reported a total of ¥3,320,921.77 in non-recurring gains for 2022, down from ¥22,648,380.54 in 2021[27]. - The company’s lactic acid product revenue was CNY 861.89 million, accounting for 56.16% of total revenue, with a slight increase of 0.32%[76]. - The revenue from lactic acid salts surged by 25.68% to CNY 297.51 million, representing 19.39% of total revenue[76]. - Domestic sales contributed CNY 1,014.17 million, which is 66.09% of total revenue, with a growth of 4.36%[76]. - International sales increased by 10.65% to CNY 520.44 million, making up 33.91% of total revenue[76]. Dividend Distribution - The company plans to distribute a cash dividend of 1.1 RMB per 10 shares to all shareholders, based on a total of 180,654,547 shares[3]. - The cash dividend distribution accounted for 100% of the total profit distribution amount, reflecting the company's commitment to shareholder returns[180]. - The company distributed a cash dividend of RMB 0.75 per 10 shares, totaling RMB 13,549,091.03 (including tax) for the year 2021[178]. Corporate Governance - The company has established a comprehensive internal control system to ensure effective execution of its operational strategies and risk management[183]. - The company has maintained a governance structure that supports effective decision-making and operational transparency[182]. - The company has a structured remuneration decision-making process that requires approval from the board of directors and the supervisory board, followed by shareholder meeting approval[161]. - The company has appointed independent directors with extensive academic and professional backgrounds, enhancing governance and oversight[160]. - The company has established a management system for hedging activities to improve operational compliance and risk oversight[111]. - The company has established a comprehensive risk management framework to monitor and mitigate potential risks identified during the reporting period[173]. Research and Development - The company is focusing on expanding its biodegradable materials research and development initiatives[150]. - The company has invested in R&D for new products and technologies in collaboration with universities to enhance its product offerings[136]. - The company’s R&D expenses increased by 11.53% to 58,531,399.45 CNY in 2022[84]. - The number of R&D personnel increased by 3.49% to 178, while the proportion of R&D personnel in the total workforce decreased slightly to 13.54%[89]. - The company is in the pilot stage of several key technology projects, including the development of high-efficiency lactic acid production methods and biodegradable materials[90]. Market Expansion and Strategy - The company plans to continue expanding its market presence and investing in new technologies to enhance production efficiency and product offerings[30]. - The company is actively pursuing market expansion and capacity enhancement through project adjustments and new product developments[121]. - The company is committed to maintaining its competitive edge by optimizing production processes and developing new products to mitigate price competition risks[136]. - The company is focused on building a biodegradable circular industry chain from lactic acid to polylactic acid to enhance product value and promote transformation and upgrading[138]. Environmental Compliance - The company strictly adhered to environmental protection laws and regulations during its operations, including the Environmental Protection Law and the Water Pollution Prevention Law[199]. - The total wastewater discharge was 186.57 tons per year, with no exceedances reported[199]. - The company maintained a CODcr discharge of 136.288 tons per year, complying with the 100 mg/L standard[199]. - The company reported a total nitrogen discharge of 90.69 tons per year, adhering to the 45 mg/L standard[200]. - The company’s sulfur dioxide emissions were recorded at 19.44 tons per year, within the permissible limits[200]. Investment and Financial Management - The company has made substantial investments in the development of new technologies and products, particularly in biodegradable materials[103]. - The company has established a procurement control system that includes supplier evaluation and contract management, ensuring that procurement meets production needs and is conducted efficiently[190]. - The investment management system requires feasibility reports for projects, with investment decisions approved by the general manager or board based on the investment amount, ensuring strict control over investment scale and risk[192]. - The company has implemented a comprehensive budget management system to clarify responsibilities and enforce budget constraints across all departments[187]. Shareholder Engagement - The company has conducted annual and temporary shareholder meetings with participation rates of 59.27% and 52.99%, respectively, indicating strong shareholder engagement[147]. - The company has maintained a stable shareholding structure with no significant changes in shareholdings among key executives[149]. - The company’s board members have extensive experience in the industry, with backgrounds in various managerial roles[151][152].

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2020-004 | --- | --- | --- | |----------------|------------------------|--------------------------| | | √ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ 其他 | | | | 太平洋证券：柳强 | | | | 东北证券：王栋，陈俊杰 | | | | 国君资管：蒋文超 | | | 参与单位名称及 | 鹏华基金：马猛 | | | 人员姓名 | 嘉实基金：陈景诚 | | | | 银华基金：侯杰瀚 | | | | 东方基金：刘腾尧 | | | 时间 | 2020 年 6 月 3 | 日上午 9:40-10:50 | | 地点 | 腾讯会议（电话调研） | | 河南金丹乳酸科技股份有限公司 河南金丹乳酸科技股份有限公司 投资者关系活动记录表 | --- | - ...

河南金丹乳酸科技股份有限公司 投资者关系活动记录表 投资者关系活动记录表 证券代码：300829 证券简称：金丹科技 编号：2020-005 河南金丹乳酸科技股份有限公司 | --- | --- | --- | |-------------------------|--------------------------|------------------------------------| | | √ | 特定对象调研 □分析师会议 | | | □媒体采访 | □业绩说明会 | | 投资者关系活动 | □ 新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □ 其他 | | | | 西南证券：杨林，薛聪 | | | | 西部证券：杨晖 | | | 参与单位名称及 人员姓名 | 广发证券：吴鑫然 | | | | 嘉实基金：王子建，陈景诚 | | | | 敦和资产：梁作强 | | | 时间 | 2020 年 6 月 8 | 日下午 17:00-18:20 | | 地点 | 公司五楼会议室 | | | 上市公司接待人 | 金丹科技营销总监申介健； | | | 员姓名 | 证券事务代表刘彦宏； ...